GE HealthCare Technologies Inc.
GEHC· Nasdaq
Filed Jul 31, 2024 · 10-Q · 31 days after period end · 0001932393-24-000044
| Metric | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|
| Revenue | $4.84B | $4.82B | $4.48B |
| Net Income | $428.00M | $418.00M | $485.00M |
| EPS Diluted | $0.93 | $0.91 | $1.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Jul 31, 2024 · 31 d after period end